Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

about

P2860

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

Item

http://www.wikidata.org/entity/Q39172440

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

@en

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

@nl

type

Item

label

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

@en

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

@nl

prefLabel

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

@en

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

@nl

P1433

Q39172440-585C8AEC-0437-4E06-B88A-172778779988

P1476

Q39172440-FE7796BF-2F40-4939-BCDA-E95AB436835A

P2093

Q39172440-3545C9C2-5177-4FD7-A446-DD8A57168829

Q39172440-36413009-C7D0-41B0-B12D-C9A2EA656426

Q39172440-7DF25EC6-114C-4F74-8303-02E6255172A2

Q39172440-88FE4CD8-CBE4-41AB-8337-2069340619A9

Q39172440-A9EFD8B4-8D3D-4889-93A9-421596C55C8E

Q39172440-AFB4014D-34FD-4E53-8BBC-C70C18FE0E83

Q39172440-B7BAD2D0-7B7E-4B09-866F-A03907520F37

Q39172440-DBC0006B-CB89-4C93-ADC9-518401E4E075

Q39172440-E1BDE68A-586D-4E1A-AEF9-0B72476EF430

P2860

Q39172440-00A93819-027F-45D1-BB07-242BC9DD77B8

Q39172440-06BA2D6B-FF03-4783-81E9-31106700A506

Q39172440-0DEC44EC-4B09-421C-B866-41AD0FBAFC0B

Q39172440-1604511D-F123-4AFB-8BB8-BD49139E6FD4

Q39172440-166A5C68-A7ED-4AAB-8CCF-37B2B541796C

Q39172440-1A091010-D090-4824-AC19-513E7B4DAD95

Q39172440-1A408098-756A-48C0-B238-3BAE05A263C5

Q39172440-1AD839A8-BA83-464A-BE50-55B90F7DC35E

Q39172440-1C1336B5-0AA1-4167-B23F-32A34C4B3FC4

Q39172440-22C2F5CF-A6E4-4396-8887-6812ABB29CBE

P304

Q39172440-C18D97BD-391B-418E-AF0C-C2AF91EF00FF

P31

Q39172440-81AABF9B-1E4C-4355-A1C9-932973C637BD

P356

Q39172440-F21C7AE9-123F-4E11-8004-24936C7B6247

P433

Q39172440-9F31D73B-9079-4E55-88E4-CAD472FC75BD

P478

Q39172440-BB04145C-F200-428E-A7AA-77D573FF9167

P50

Q39172440-55AAAF9F-DA93-4B7D-84E9-EFCB369D33F1

Q39172440-8AAA0FD6-AC9B-4960-A8F7-260870F71C19

Q39172440-9CCE39C9-65FE-4B62-A6C6-66815CC3EBB4

P577

Q39172440-365B8BF8-DBF8-46F7-BCDB-AB4DF9A381E2

P698

Q39172440-FAABB349-964D-4313-B24C-5260B5AF7727

P932

Q39172440-C15C1AF4-9331-4A6A-90F3-7F4502F8A58E

P356

EMMM.201506059

P1433

EMBO Molecular Medicine

P1476

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis

@en

P2093

Chris Kedong Wang

http://www.w3.org/2001/XMLSchema#string

Eliana Beraldi

http://www.w3.org/2001/XMLSchema#string

Fan Zhang

http://www.w3.org/2001/XMLSchema#string

Jennifer Bishop

http://www.w3.org/2001/XMLSchema#string

Ladan Fazli

http://www.w3.org/2001/XMLSchema#string

Nader Al Nakouzi

http://www.w3.org/2001/XMLSchema#string

Susan Ettinger

http://www.w3.org/2001/XMLSchema#string

Wolfgang Jager

http://www.w3.org/2001/XMLSchema#string

Yohann Loriot

http://www.w3.org/2001/XMLSchema#string

P2860

Clusterin inhibits apoptosis by interacting with activated Bax

Plk1 promotes nuclear translocation of human Cdc25C during prophase

Clusterin: a key player in cancer chemoresistance and its inhibition

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis

Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Temporal and spatial control of cyclin B1 destruction in metaphase

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

P304

761-778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMMM.201506059

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anne Chauchereau

Lucia Nappi

Martin E Gleave

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27198502

http://www.w3.org/2001/XMLSchema#string

P932

4931290

http://www.w3.org/2001/XMLSchema#string